"Wolstan & Goldberg Eye Associates has served the Los Angeles South Bay area for more than 30 years and is dedicated to continuing its tradition of providing outstanding ophthalmology procedures and eye care. With four highly trained and experienced surgeons on staff, Wolstan & Goldberg Eye Associates offers a very comprehensive range of ophthalmology procedures, including cataract replacement, LASIK surgery, cornea transplants, and retinal surgery. Call us now to request an appointment!"

During the past decade, Wolstan & Goldberg Eye Associates conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 15 clinical trials were completed, i.e. on average, 65.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 13 clinical trials were completed. i.e. 130% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wolstan & Goldberg Eye Associates" #1 sponsor was "Allergan" with 5 trials, followed by "Johnson & Johnson Surgical Vision, Inc." with 5 trials sponsored, "Kala Pharmaceuticals, Inc." with 3 trials sponsored, "Shire" with 3 trials sponsored and "Abbott Medical Optics" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wolstan & Goldberg Eye Associates" #1 collaborator was "Clinical Research Consultants, Inc." with 1 trials as a collaborator and "National Eye Institute (NEI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Wolstan & Goldberg Eye Associates" are "Cataract" (7 trials), "Ocular Hypertension" (3 trials), "Corneal Astigmatism" (2 trials), "Dry Eye" (2 trials) and "Dry Eye Syndromes" (2 trials). Many other conditions were trialed in "Wolstan & Goldberg Eye Associates" in a lesser frequency.

Most popular intervention types in "Wolstan & Goldberg Eye Associates" are "Drug" (18 trials), "Device" (9 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Bimatoprost SR" (2 trials), "SHP640" (2 trials), "Vehicle" (2 trials) and "0.005% Lacripep" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wolstan & Goldberg Eye Associates" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Wolstan & Goldberg Eye Associates". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Wolstan & Goldberg Eye Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Wolstan & Goldberg Eye Associates, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".